[null, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "https://europeancitizendotorg.files.wordpress.com/2011/12/1342768011.jpg", "src": "https://europeancitizendotorg.files.wordpress.com/2011/12/1342768011.jpg", "alt_text": "Image result for On World AIDS Day, WHO calls for an end to discrimination"}, null, null, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "https://www.archcare.org/sites/default/files/archcare-hd-unit_0.jpg", "src": "https://www.archcare.org/sites/default/files/archcare-hd-unit_0.jpg", "formatted_filename": "archcare hd unit", "alt_text": "Image result for Huntington's disease"}, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2017/1-gene.jpg", "src": "https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2017/1-gene.jpg", "formatted_filename": "gene", "alt_text": "Image result for Scientists discover a medicine that can treat Huntington's disease"}, null, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "https://static.euronews.com/articles/135453/684x384_135453.jpg", "src": "https://static.euronews.com/articles/135453/684x384_135453.jpg", "alt_text": "Image result for leprosy as a \"forgotten disease\""}, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "https://cdn.images.express.co.uk/img/dynamic/78/590x/secondary/107832.jpg", "src": "https://cdn.images.express.co.uk/img/dynamic/78/590x/secondary/107832.jpg", "alt_text": "Image result for leprosy as a \"forgotten disease\""}, null, null, null, null, null, {"document_url": "http://www.hyperbaric-oxygen-info.com/articles/page/2/", "unformatted_src": "http://images.indianexpress.com/2017/12/diabetes-759.jpg", "src": "http://images.indianexpress.com/2017/12/diabetes-759.jpg", "formatted_filename": "diabetes", "alt_text": "Image result for Researchers identify 5 types of diabetes"}, null, null, null, null]
“If we want to have universal health coverage and eliminate AIDS and hepatitis, everyone should collaborate,” Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, said in a statement.

The World Health Organization (WHO) on Friday urged World AIDS Day that there should be no “discrimination” and the collaboration of all to fight against this disease. “Health services should adapt to meet and meet the needs of the most exposed and affected populations and this includes a policy of zero tolerance of stigma and discrimination in all health services,” Tedros said.

In the statement, the doctor asks “how is it possible after decades of recognition of the key role of communities in conducting HIV response, men who have sex with men, sex workers, transgender people, drug users and prisoners, who accounted for 40 % of infections by 2016, continue to face barriers to accessing the most basic health services. ”

In addition, many young women, adolescents, immigrants and displaced persons are particularly vulnerable, according to Tedros.

However, the doctor acknowledged that “we have advanced a lot in the last 30 years” since “today 21 million people are receiving retroviral treatment against the disease that allows them to live full and productive lives.”

“There are fewer people infected with HIV every day and there are fewer deaths as well, but these successes are hiding the many disparities and challenges that remain,” he warned.

According to the Blind Spot report published today by the Joint United Nations Program on HIV and AIDS (UNAIDS), less than 50% of men with HIV are in treatment compared to 60% of women. In addition, men are less likely to have access to HIV treatment and greater risk of dying from AIDS-related illnesses, accounting for 58% of the 1 million AIDS-related deaths in 2016.

Globally, 36.7 million people are living with HIV, of which 20.9 million had access to retroviral treatment by the middle of 2017, four times more than in 2000 and 1.2 more than in 2015.

Studies further show that men are more likely to start treatment late and to stop it.

“The response to HIV has played a key role in transforming public health and, in turn, influences the universal health coverage agenda,” concluded WHO Director-General. The treatment, which consists of the injection of a drug, is the first developed to reduce the production of the mutant toxic huntingtin, the underlying cause of the disease.

For the first time, a drug under development has been shown to slow the progression of the degenerative Huntington ‘s disease, which is genetic in origin and has devastating effects, the Pharma Web site said on Monday.

The treatment, which consists of the injection of a drug, is the first developed to reduce the production of the mutant toxic huntingtin, the underlying cause of the disease, according to a statement from Ionis, the pharmaceutical company that is developing it. Although still in a state of clinical development, IONIS-HTTRx – the official name of the drug – is presented as the first innovation of its kind in efforts to contain this pathology.

“The key is now to move quickly to a larger testing process to see if it slows the progress of the disease,” said Sarah Tabrizi, the lead researcher for the project.

Innovation offers an alternative for all who suffer from Huntington’s disease, regardless of the individual mutation of each, making it “unique. ”

In the tests performed with the remedy, the researchers observed a reduction of the huntingtin protein. The drug was also safe and well tolerated, which led to its continued development.

There is currently no treatment to correct Huntington’s disease and the drugs focus on attenuating and controlling their symptoms.

Huntington’s disease is genetic, rare and neurodegenerative, and causes deterioration of mental abilities and physical control. The condition usually appears in people between the ages of 30 and 50 to continue to worsen for a period of 10 to 25 years. In addition, the disease affects 30,000 people and threatens another 200,000 in the United States alone, as the company recalled in the statement.

The treatment license was recently acquired by Roche, which will be in charge of finalizing its development and its subsequent commercialization after the payment of US $ 45 million.

In the first half of 2018, both Roche and Ionis, the two pharmacists involved in drug development, are expected to present the results of their studies in scientific journals. The highest number of cases of leprosy are recorded in India, Brazil, and Indonesia.

The United Nations special rapporteur on the elimination of discrimination against people with leprosy, Portugal’s Alice Cruz, said on Thursday that the disease remains a “forgotten disease” despite statistics showing more than 200,000 cases per year.

Cruz called for the social stigma surrounding people with this disease to be eradicated, as they still suffer from discrimination and, in many cases, do not have access to medicines. In a statement, the expert pointed out that the highest number of cases are registered in India, Brazil, and Indonesia.

Bangladesh, Democratic Republic of Congo, Ethiopia, Madagascar, Mozambique, Myanmar, Nepal, Nigeria and the Philippines are some of the 22 countries identified by the World Health Organization (WHO) where the medical action is a priority.

In 2016, there were 214,783 new cases of leprosy or leprosy, as the disease is popularly known, of which 12,437 suffered serious disabilities.

“This level of disability is alarming and completely unnecessary,” Cruz said on the occasion of the commemoration of World Leprosy Day on January 28.

“No one with this pathology should be incapacitated,” said the rapporteur, who explained that the disease can be cured through treatment with several drugs “if it is detected and treated early enough” because otherwise “it may cause reactions severe immune disorders “such as chronic disability or pain. “The fact that this still occurs in 2018 shows that there are deficiencies in the diagnosis and lack of access to high-quality treatment,” he added.

In addition, Cruz pointed out that ” discrimination unnecessarily perpetuates the suffering of these people” and that “it is fundamental” to address causes from the root.

“Discrimination is linked to old stigmas that lead to segregation and violations of the human rights of those affected. This misconception must be approached with information and education, “said Cruz.

The specialist warned that this stigma is only “the tip of the iceberg” and denounced that these people continue to have their most basic human rights denied. BRICS countries, which account for more than 40% of the world’s population and 25% of the wealth produced, accumulate 42% of cancer-related deaths.

Brazil, Russia, India, China and South Africa, the major emerging economies are known as BRICS, lost $ 46.2 billion in 2012 in productivity because of premature deaths related to tumors, according to the International Agency for Research on Cancer ). “Studying the economic impact of cancer in emerging economies leads us to think about the importance of stopping preventable cancers in these countries. It’s not just about the high human cost but also about its impact on the economy, “said lead author Alison Pearce.

IARC, based in Lyon, South East France, calls on these countries to promote “lifestyle changes” – avoiding a sedentary lifestyle, drinking alcohol and smoking – to prevent these diseases.

The agency also calls for more health policies to be implemented and cites as an example the vaccination against hepatitis B virus to prevent liver cancer, especially in China, or directed against human papillomavirus (HPV) to prevent cancer of the cervix.

By country, the IARC warns of the rapid “growth of obesity rates” in Brazil as a risk factor, in the same way as tobacco.

“Despite successful tobacco control policies, as implemented in Brazil, this substance remains a significant increase in risk” in both Brazil and South Africa said the study.

In India, chewing tobacco is “one of the major factors” associated with premature mortality related to lip and oral cavity cancers.

China, the most populated BRICS, is the country with the highest productivity losses, US $ 28 billion, due to cancerous tumors such as liver cancer, while in Russia, head and neck cancers appear to be related to high alcohol intake. Why It Is Worth To Be Aware Of Its Existence… 

— Seva Brodsky, a road accident victim 

Dear Visitor,

Kind regards,